Product Information
CLINDA-TRETINOIN 1.2%-0.025% is a generic product labeled by Oceanside Pharmaceuticals, priced at $6.2993 per GM under NDC 68682030060. Its NADAC has been published 77 times since Apr 17, 2024.
FDA first approved this application on Nov 7, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12; .25 mg/g; mg/g
Manufacturer
Oceanside PharmaceuticalsNDC
68682030060
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
CLINDAMYCIN PHOSPHATE; TRETINOINApproval Type
Authorized Generic (NDA)
FDA Application
NDA050802FDA Approved
11/7/2006
TE Code
AB1
On Market Since
8/4/2020
Pharmacological Classes
Price Statistics
The NADAC for CLINDA-TRETINOIN 1.2%-0.025% has been published 77 times since Apr 17, 2024, and over the history we have for it it has risen 18.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.2993 per GM |
|---|---|
| All-time high | $6.9072 (Aug 13, 2025) |
| All-time low | $4.7546 (Oct 23, 2024) |
| 52-week high | $6.5652 |
| 52-week low | $6.2993 |
| Median price | $5.3369 |
| Average price | $5.6344 |
| Largest weekly change | +7.1% (May 21, 2025) |
| Weeks tracked | 77 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-4.0%
3Y
N/A
5Y
N/A
All
+18.0%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLINDA-TRETINOIN 1.2%-0.025%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDA-TRETINOIN 1.2%-0.025%, manufactured by Oceanside Pharmaceuticals, is $6.2993 per GM (NDC 68682030060), effective Oct 1, 2025.
How has the price of CLINDA-TRETINOIN 1.2%-0.025% changed over time?
Over the history we have for it, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has risen 18.0%. It has been tracked across 77 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CLINDA-TRETINOIN 1.2%-0.025%?
Since Apr 17, 2024, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has ranged from a low of $4.7546 (Oct 23, 2024) to a high of $6.9072 (Aug 13, 2025), with a median of $5.3369 per GM.
Are there cheaper alternatives to CLINDA-TRETINOIN 1.2%-0.025%?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDA-TRETINOIN 1.2%-0.025%, is $4.3997 per GM — about 30% below CLINDA-TRETINOIN 1.2%-0.025%.
Who manufactures CLINDA-TRETINOIN 1.2%-0.025%?
CLINDA-TRETINOIN 1.2%-0.025% (NDC 68682030060) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.